SCHEMBL23745371

SCHEMBL23745371

CC(CC1(C2CC2)NC(O)NC1=O)C(=O)N1Cc2ccc(C(F)(F)F)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ DPP7 Q9UHL4 2/20 0.48
▸ ADAMTS5 Q9UNA0 14/20 0.42
▸ ADAMTS4 O75173 4/20 0.42
▸ ADAM17 P78536 4/20 0.42
▸ MMP13 P45452 7/20 0.41
▸ MMP2 P08253 6/20 0.41
▸ MMP14 P50281 3/20 0.39
▸ MMP3 P08254 2/20 0.39
▸ MMP12 P39900 2/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ NAMPT P43490 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CCR2 P41597 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31121196 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL23745208 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL31121172 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL23745210 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL23745286 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL23745207 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL23745283 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL23745205 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL23728086 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13
SCHEMBL31121170 0.85 ADAMTS5 (0.59) DPP7ADAMTS5ADAMTS4ADAM17MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021158626-A1 ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF Eternity Bioscience Inc. (US) 2021-08-12 — — WO disclosed
Send feedback